Safety trials for a whole-virus vaccine made up of four strains that are chemically inactivated and noninfectious have begun. Volunteers are randomly assigned to one of three study groups and receive either a flu vaccine, Placebo, or an inactive drug in order for them not to know what they’re receiving. The only requirement is that you cannot have gotten any type of vaccinations within eight weeks prior to enrollment in this trial so there’s risk involved with participation but it may help save your life!
The first phase of this trial will involve volunteers being randomly assigned to one of three groups, all receiving either a vaccine or placebo. The main difference between these Treatment Groups is that Group A gets BPL-1357 intramuscularly along with nasal spray saltwater; group C’s members get shots both at home and in-clinic settings without knowing which treatment they’re getting! All patients must not have gotten any type of seasonal flu shot for 8 weeks prior to enrolling – but you can still go ahead and opt-out if need be (though it might make your results worse).
What do we hope for?
This will be an interesting study to watch because it could lead to newer avenues regarding how we might combat influenza viruses going forward!